HOME >> BIOLOGY >> NEWS
JCI table of contents: June 21, 2007

Editor's Pick:A diet rich in omega-3 fatty acids may lower prostate cancer genetic risk

A diet rich in omega-3 polyunsaturated fatty acids found in certain fish or fish oil, nuts, seeds, and vegetable oils may help lower prostate cancer risk in individuals with a genetic predisposition to cancer. So conclude researchers from Wake Forest University School of Medicine in their study appearing online on June 21 in advance of publication in the July print issue of the Journal of Clinical Investigation.

While many genetic mutations are known to predispose to cancer, it has remained unclear whether dietary fat can modulate the risk of developing cancer in genetically predisposed individuals. Some studies suggest that a diet rich in omega-3 polyunsaturated fatty acids reduces cancer incidence. To determine the influence of fatty acids on prostate cancer risk in animals with a defined genetic predisposition to cancer, Yong Chen and colleagues studied Pten-knockout mice (which are predisposed to develop prostate tumors) and the effects on these mice of diets with defined levels of specific polyunsaturated fatty acids. The authors found that a nutritionally balanced diet high in omega-3 fatty acid reduced prostate tumor growth and increased survival in these animals, whereas omega-6 fatty acids had the opposite effects. Furthermore, introduction into the Pten-knockout mice of the enzyme omega-3 desaturase, which converts omega-6 to omega-3, reduced tumor growth in a manner similar to the omega-3 rich diet. The researchers went on to show that the effect of polyunsaturated fatty acids on prostate cancer development is mediated in part through cell death that is dependent on a protein known as Bad. Together, the data highlight the importance of the interaction between genes and diet in prostate cancer and imply a beneficial effect of omega-3 polyunsaturated fatty acids on delaying the onset of human prostate cancer. It will be interesting in future studies
'"/>

Contact: Brooke Grindlinger
press_releases@the-jci.org
212-342-9006
Journal of Clinical Investigation
21-Jun-2007


Page: 1 2 3 4 5 6 7

Related biology news :

1. Antioxidant overload may underlie a heritable human disease
2. JCI table of contents: Aug. 9, 2007
3. JCI table of contents: August 1, 2007
4. US Department of Defense awards $1.6 million for implantable biochip research
5. More fish oil, less vegetable oil, better for your health
6. JCI table of contents -- July 26, 2007
7. JCI table of contents: July 19, 2007
8. JCI table of contents: July 12, 2007
9. JCI table of contents: June 14, 2007
10. Food safety begins as vegetables grow
11. Turning the tables in chemistry

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... (PRWEB) , ... July 01, 2020 , ... ... presented its phase 1a findings of Neihulizumab, a biologic for the treatment of ... June 2020. Led by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson ...
(Date:7/1/2020)... , ... July 01, 2020 , ... ... awareness and solutions for glioblastoma—the most common and aggressive adult brain cancer—announced today ... JD, PhD. Senior Fellows are charged with supporting the organization’s initiatives and overall ...
(Date:6/25/2020)... (PRWEB) , ... June 24, 2020 , ... ... cloud-based enterprise software and software-driven clinical data services that accelerate drug development, is ... low-dose selinexor, an XPO1 inhibitor, in hospitalized patients with severe COVID-19. This is ...
Breaking Biology News(10 mins):
(Date:9/1/2020)... RIDING, Va. (PRWEB) , ... September 01, 2020 ... ... firm for life sciences, biotechnology, and diagnostics companies, has announced the placement of ... . Averill will be responsible for leading all financial operations and implementing key ...
(Date:8/15/2020)... ... August 13, 2020 , ... True Terpenes , the leading ... Scientific Advisory Board (SAB) to research the medical potential of terpenes and the potential ... combined with terpenes. The board is focused on expanding the recently launched line of ...
(Date:8/12/2020)... LEXINGTON, Mass. (PRWEB) , ... August 11, 2020 ... ... awarded $300,000 a year to expand the Facioscapulohumeral Muscular Dystrophy Clinical Trial ... year in 2021 and 2022. The network is a consortium of academic research ...
(Date:8/12/2020)... ... August 12, 2020 , ... Inc. magazine today revealed that ... FDA compliance consulting has been named on its annual Inc. 5000 list, the ... unique look at the most successful companies within the American economy’s most dynamic ...
Breaking Biology Technology:
Cached News: